Diabetes Core Update cover image

Diabetes Core Update – February 2024

Diabetes Core Update

00:00

Low-Dose Anti-Thimocyte Globulin for Type One Diabetes

This chapter discusses a study on the use of low-dose anti-thimocyte globulin as a treatment for stage two type one diabetes. They explore the background of the study, the pilot study that led to larger confirmatory results, and the implementation of anti-thimocyte globulin as a viable treatment option.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app